It’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ages, especially in the late ...

It has taken decades to overcome the many scientific and technical barriers that stopped us from being able to provide routine prevention of respiratory syncytial virus (RSV) lower respiratory tract ...

Respiratory syncytial virus, or RSV, is often dismissed as just another cold virus. But in reality, it's the leading cause of hospitalizations for infants under one year of age worldwide. As ...

New Centers for Disease Control and Prevention data is showing that newly released RSV vaccines are highly effective at keeping infants from becoming hospitalized. The CDC says nirsevimab was 90% ...

As the Centers for Disease Control and Prevention (CDC) finds that only one-quarter of older adults have received their respiratory syncytial virus (RSV) vaccine, the American Lung Association (ALA) ...

CHARLOTTE — The Food and Drug Administration approved a new vaccine to help protect infants from RSV on Monday. The treatment is called Enflonsia. It is a monoclonal antibody made by Merck. It’s given ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized with severe lung infections, found a new study published in The Lancet Child ...

Clesrovimab-cfor provides a fixed 105-mg dose, simplifying administration and offering five months of protection against RSV in infants. The CLEVER trial demonstrated a 60.5% reduction in ...

Each winter, worried parents have flooded health care providers’ offices with sick babies, hoping for treatment that could help their infant recover from this “stubborn cold.” Many parents don’t ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests. Researchers found the respiratory syncytial virus (RSV) ...